108-110 °C(Solv: methanol (67-56-1); water (7732-18-5))
密度:
1.09±0.1 g/cm3(Predicted)
计算性质
辛醇/水分配系数(LogP):
4.2
重原子数:
18
可旋转键数:
1
环数:
3.0
sp3杂化的碳原子比例:
0.06
拓扑面积:
28.2
氢给体数:
0
氢受体数:
1
反应信息
作为产物:
描述:
2-吡啶乙腈 、 2-溴-4'-甲基苯乙酮 在
silica gel 、 乙酸乙酯 、 正己烷 、 water ethanol 作用下,
以
丙酮 为溶剂,
反应 24.0h,
以to give 2-(4-methylphenyl)indolizine-1-carbonitrile (4.1 g) as a pale brown powder的产率得到2-p-tolyl-indolizine-1-carbonitrile
参考文献:
名称:
Angiotensin II antagonizing heterocyclic derivatives
Angiotensin II antagonizing heterocyclic derivatives
申请人:Fujisawa Pharmaceutical Co., Ltd.
公开号:US05210092A1
公开(公告)日:1993-05-11
The invention concerns compounds of the formula ##STR1## represents a condensed or uncondensed imidazolyl ring and the rest of the variables are defined in the specification. They are angiotensin II antagonists useful for treating hypertension, etc.
Imidazole derivatives, potent and selective antagonists of angiotensin II receptor
申请人:FUJISAWA PHARMACEUTICAL CO., LTD.
公开号:EP0480204B1
公开(公告)日:1996-03-20
US5210092A
申请人:——
公开号:US5210092A
公开(公告)日:1993-05-11
US5215994A
申请人:——
公开号:US5215994A
公开(公告)日:1993-06-01
Angiotenin II antagonizing heterocyclic derivatives
申请人:Fujisawa Pharmaceutical Co., Ltd.
公开号:US05215994A1
公开(公告)日:1993-06-01
The invention relates to compounds of the formula ##STR1## wherein ##STR2## represents a condensed or uncondensed imidazolyl ring and the rest of the variables are as defined in the specification. They are angiotensin II antagonists useful for treating hypertension, etc..